$GNPX
Genprex Inc

2022 Q3 Form 10-Q Financial Statement

#000143774922020379 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.511M $2.432M $3.856M
YoY Change 25.53% -1.08% -10.75%
% of Gross Profit
Research & Development $3.593M $2.737M $1.861M
YoY Change 150.93% 79.33% -14.21%
% of Gross Profit
Depreciation & Amortization $6.224K $6.543K $6.730K
YoY Change -4.08% 129.74% 7.82%
% of Gross Profit
Operating Expenses $3.593M $2.737M $1.861M
YoY Change 150.93% 79.33% -14.21%
Operating Profit -$6.111M -$5.175M -$5.723M
YoY Change 77.69% 29.79% -11.84%
Interest Expense $27.88K $5.740K $880.00
YoY Change 2530.19% 421.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.083M -$5.169M -$5.722M
YoY Change 76.93% 29.68% -11.83%
Income Tax
% Of Pretax Income
Net Earnings -$6.083M -$5.169M -$5.722M
YoY Change 76.93% 29.68% -11.82%
Net Earnings / Revenue
Basic Earnings Per Share -$0.13 -$0.11 -$0.12
Diluted Earnings Per Share -$126.8K -$107.9K -$119.5K
COMMON SHARES
Basic Shares Outstanding 48.02M 47.89M 47.88M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.52M $30.05M $34.56M
YoY Change -39.28% -32.07% -26.59%
Cash & Equivalents $25.52M $30.05M $34.56M
Short-Term Investments
Other Short-Term Assets $757.3K $847.8K $1.116M
YoY Change 1.1% 12.2% 457.8%
Inventory
Prepaid Expenses
Receivables $34.85K $32.17K
Other Receivables $0.00 $0.00
Total Short-Term Assets $26.31M $30.90M $35.70M
YoY Change -42.36% -35.71% -29.13%
LONG-TERM ASSETS
Property, Plant & Equipment $29.11K $35.33K $41.88K
YoY Change -34.35% -10.53% 12.27%
Goodwill
YoY Change
Intangibles $682.1K $666.0K $644.2K
YoY Change 8.72% 7.48% 5.49%
Long-Term Investments
YoY Change
Other Assets $3.609M $3.629M $3.664M
YoY Change 465.51% 475.65% 489.67%
Total Long-Term Assets $3.638M $3.664M $3.706M
YoY Change 433.03% 446.99% 462.64%
TOTAL ASSETS
Total Short-Term Assets $26.31M $30.90M $35.70M
Total Long-Term Assets $3.638M $3.664M $3.706M
Total Assets $29.95M $34.57M $39.41M
YoY Change -35.36% -29.07% -22.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $683.9K $683.3K $1.253M
YoY Change 15.53% 84.79% 268.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.457M $2.154M $2.385M
YoY Change 111.49% 105.67% 288.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.457M $2.154M $2.385M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.457M $2.154M $2.385M
YoY Change 111.49% 105.67% 290.95%
SHAREHOLDERS EQUITY
Retained Earnings -$94.99M -$88.91M -$83.74M
YoY Change 31.32% 29.05% 29.01%
Common Stock $48.02K $47.90K $47.88K
YoY Change 0.45% 0.79% 1.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.49M $32.41M $37.02M
YoY Change
Total Liabilities & Shareholders Equity $29.95M $34.57M $39.41M
YoY Change -35.36% -29.07% -22.78%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.083M -$5.169M -$5.722M
YoY Change 76.93% 29.68% -11.82%
Depreciation, Depletion And Amortization $6.224K $6.543K $6.730K
YoY Change -4.08% 129.74% 7.82%
Cash From Operating Activities -$4.571M -$4.538M -$4.084M
YoY Change 73.49% 53.2% -25.28%
INVESTING ACTIVITIES
Capital Expenditures -$16.05K -$21.85K $0.00
YoY Change -15.66% -130.01% -100.0%
Acquisitions
YoY Change
Other Investing Activities $48.30K $57.33K $12.16K
YoY Change -74.22% -238.75% -221.6%
Cash From Investing Activities $32.25K $35.48K $10.32K
YoY Change -80.84% 12.67% -109.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.750K 0.000 $0.00
YoY Change -99.28% -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -4.571M -4.538M -$4.084M
Cash From Investing Activities 32.25K 35.48K $10.32K
Cash From Financing Activities 1.750K 0.000 $0.00
Net Change In Cash -4.537M -4.502M -$4.074M
YoY Change 104.1% 59.87% -120.63%
FREE CASH FLOW
Cash From Operating Activities -$4.571M -$4.538M -$4.084M
Capital Expenditures -$16.05K -$21.85K $0.00
Free Cash Flow -$4.555M -$4.516M -$4.084M
YoY Change 74.14% 48.8% -26.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47898351
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47898351
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47874708
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47874708
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38244
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0772347
dei Entity Address Address Line1
EntityAddressAddressLine1
3300 Bee Cave Road, #650-227
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78746
dei City Area Code
CityAreaCode
512
dei Local Phone Number
LocalPhoneNumber
537-7997
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GNPX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
511348 usd
us-gaap Costs And Expenses
CostsAndExpenses
10898433 usd
us-gaap Costs And Expenses
CostsAndExpenses
10478917 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5175070 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
30900823 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3987222 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10898433 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
39140224 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35334 usd
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48020304
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6287295 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6774407 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30053021 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38628876 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
5175070 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
3987222 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
847802 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48608 usd
CY2022Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
10000 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8691 usd
CY2022Q2 gnpx Research And Development Assets Noncurrent
ResearchAndDevelopmentAssetsNoncurrent
2952917 usd
CY2021Q4 gnpx Research And Development Assets Noncurrent
ResearchAndDevelopmentAssetsNoncurrent
3022403 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
666049 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
642360 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3628966 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3673454 usd
CY2022Q2 us-gaap Assets
Assets
34565123 usd
CY2021Q4 us-gaap Assets
Assets
42862286 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
683323 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
973195 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1470515 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
612100 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2153838 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1585295 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
47898 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
47874 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
121273050 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119246970 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88909663 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78017853 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32411285 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41276991 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34565123 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42862286 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Depreciation
Depreciation
6543 usd
CY2021Q2 us-gaap Depreciation
Depreciation
2848 usd
us-gaap Depreciation
Depreciation
13274 usd
us-gaap Depreciation
Depreciation
9090 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2737028 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1526277 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4597864 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3695420 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2431499 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2458097 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3086 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5169326 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3986118 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10478917 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
5744 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1104 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6623 usd
us-gaap Net Income Loss
NetIncomeLoss
-10891810 usd
us-gaap Net Income Loss
NetIncomeLoss
-10475831 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47893404
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47372490
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47892919
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46464343
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
30916490 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25324330 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20650 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
651088 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6489714 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
50422845 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
110033 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
21100 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1116358 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3986118 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
47684218 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41276991 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17500 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1452607 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5722484 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
37024614 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17972 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
538026 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5169326 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32411285 usd
us-gaap Net Income Loss
NetIncomeLoss
-10891810 usd
us-gaap Net Income Loss
NetIncomeLoss
-10475831 usd
us-gaap Depreciation
Depreciation
13274 usd
us-gaap Depreciation
Depreciation
9090 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2026104 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1809196 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
337762 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
371043 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-289872 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
176824 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
858415 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
419671 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8621651 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8432093 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9142 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
23689 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18048 usd
gnpx Payments For Proceeds From Research And Development Supplies
PaymentsForProceedsFromResearchAndDevelopmentSupplies
-69485 usd
gnpx Payments For Proceeds From Research And Development Supplies
PaymentsForProceedsFromResearchAndDevelopmentSupplies
51315 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45796 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78505 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25434363 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25434363 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8575855 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16923765 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38628876 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27319684 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30053021 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44243449 usd
CY2018Q1 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><span style="text-decoration: underline; "><i>Use of Estimates</i></span></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of our unaudited condensed financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
29757127 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
38392886 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
28650 usd
gnpx Stock Issued During Period Shares Exercise Of Cashless Warrants
StockIssuedDuringPeriodSharesExerciseOfCashlessWarrants
13643
CY2022Q2 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
2952917 usd
CY2021Q4 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
3022403 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
10000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
670889
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
677912 usd
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
86138
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
156045 usd
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47898351
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2154747
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.37
CY2021 gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
50000
CY2021 gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
5.29
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2204747
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.39
CY2021 gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
-112993
CY2021 gnpx Class Of Warrant Or Right Cancelled During Period Exercise Price
ClassOfWarrantOrRightCancelledDuringPeriodExercisePrice
4.47
CY2021 gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
-13643
CY2021 gnpx Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.50
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2078111
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.41
CY2022Q2 gnpx Class Of Warrant Or Right Vested Or Expected To Vest
ClassOfWarrantOrRightVestedOrExpectedToVest
0
CY2022Q2 gnpx Class Of Warrant Or Right Vested Or Expected To Vest Weighted Average Exercise Price
ClassOfWarrantOrRightVestedOrExpectedToVestWeightedAverageExercisePrice
0
CY2022Q2 gnpx Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1844776
CY2022Q2 gnpx Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
4.66
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11448967
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2892166
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
17500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.00
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2519628
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
118507
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
670889
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M23D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M26D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6844069
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.81
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2519628
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.26
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
670889
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.01
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
118507
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.00
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8574301
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2892166
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.18
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
17500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11448967
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.06
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
235465
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.32
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6166620
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.20
CY2022Q1 us-gaap Other Commitment
OtherCommitment
340000 usd

Files In Submission

Name View Source Status
0001437749-22-020379-index-headers.html Edgar Link pending
0001437749-22-020379-index.html Edgar Link pending
0001437749-22-020379.txt Edgar Link pending
0001437749-22-020379-xbrl.zip Edgar Link pending
ex_389031.htm Edgar Link pending
ex_389032.htm Edgar Link pending
ex_389033.htm Edgar Link pending
ex_407419.htm Edgar Link pending
ex_407420.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gnpx-20220630.xsd Edgar Link pending
gnpx20220630_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gnpx-20220630_lab.xml Edgar Link unprocessable
gnpx-20220630_pre.xml Edgar Link unprocessable
gnpx-20220630_def.xml Edgar Link unprocessable
gnpx-20220630_cal.xml Edgar Link unprocessable
gnpx20220630_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable